NUVAIRA
Nuvaira is a new alternative COPD treatment option that specializes in developing devices for treating lung diseases. Nuvaira is currently working on a novel catheter-based system that has the potential to improve lung function, exercise capacity, and quality of life for patients with chronic obstructive pulmonary disease. It was founded in 2008 and headquartered in Minneapolis, Minnesota.
NUVAIRA
Social Links:
Industry:
Biotechnology Health Care Information Technology Medical Device
Founded:
2008-01-01
Address:
Minneapolis, Minnesota, United States
Country:
United States
Website Url:
http://www.nuvaira.com
Total Employee:
11+
Status:
Active
Contact:
(763)450-2800
Email Addresses:
[email protected]
Total Funding:
188.86 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt WordPress Google Universal Analytics Domain Not Resolving Wordpress Plugins
Similar Organizations
Gamida Cell
Gamida Cell is an advanced cell therapy company committed to finding cures for patients with blood cancers and serious blood diseases.
Impel NeuroPharma
Impel NeuroPharma is a medical device company that develops a novel drug delivery device that uses direct nose-to-brain delivery.
Injectsense
Monitoring therapy effectiveness (glaucoma) through miniaturized, autonomous in-vivo sensing and data uploading to cloud database.
Intarcia Therapeutics
Intarcia Therapeutics develops therapies for diseases that require long-term chronic treatment.
ReShape Lifesciences
ReShape Lifesciencesis a developer of minimally invasive medical devices to treat obesity and metabolic diseases.
Senseonics
Senseonics is a medical device startup company that focuses on the design, development, and commercialization of glucose monitoring systems.
Current Advisors List
Current Employees Featured
Founder
Investors List
U.S. Venture Partners
U.S. Venture Partners investment in Series E - Nuvaira
Vertex Ventures HC
Vertex Ventures HC investment in Series E - Nuvaira
Qiming Venture Partners
Qiming Venture Partners investment in Series E - Nuvaira
Richard King Mellon Foundation
Richard King Mellon Foundation investment in Series E - Nuvaira
Windham Venture Partners
Windham Venture Partners investment in Series E - Nuvaira
Split Rock Partners
Split Rock Partners investment in Series E - Nuvaira
Advanced Technology Ventures
Advanced Technology Ventures investment in Series E - Nuvaira
Versant Ventures
Versant Ventures investment in Series E - Nuvaira
Endeavour Vision
Endeavour Vision investment in Series E - Nuvaira
Morgenthaler Ventures
Morgenthaler Ventures investment in Series E - Nuvaira
Key Employee Changes
| Date | New article |
|---|---|
| 2020-02-05 | Nuvaira announces Griffin as new CFO |
Official Site Inspections
http://www.nuvaira.com
- Host name: 141.193.213.20
- IP address: 141.193.213.20
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Nuvaira"
About Us - Nuvaira
Nuvaira, Inc. develops innovative and groundbreaking therapies that aim to improve the lives of the more than 65 million people around the world with obstructive lung disease. Founded in …See details»
Nuvaira - Crunchbase Company Profile & Funding
Nuvaira is a new alternative COPD treatment option that specializes in developing devices for treating lung diseases. Nuvaira is currently working on a novel catheter-based system that has …See details»
Nuvaira
DNerva Lung Denervation System . The dNerva Lung Denervation System is a catheter-based system used to complete a one-time, out-patient, bronchoscopic procedure to disrupt nerve …See details»
Nuvaira - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Access exclusive financial …See details»
Nuvaira 2025 Company Profile: Valuation, Funding
Nuvaira General Information Description. Developer of a medical device designed to improve outcomes for patients suffering from obstructive lung diseases. The …See details»
Nuvaira Announces a $79 Million Financing Round to Pursue ...
Nuvaira is the first interventional pulmonary company to pursue and report one-year randomized, double-blinded and sham-controlled clinical evidence in COPD patients from a Phase 2b trial. …See details»
Nuvaira, Inc. Company Profile | Maple Grove, MN | Competitors ...
Find company research, competitor information, contact details & financial data for Nuvaira, Inc. of Maple Grove, MN. Get the latest business insights from Dun & Bradstreet.See details»
Nuvaira - 2025 Company Profile, Funding & Competitors - Tracxn
Mar 10, 2025 Nuvaira - Provider of a catheter-based system for patients suffering from COPD. Raised a total funding of $191M over 9 rounds from 13 investors. Founded by Martin Mayse …See details»
Nuvaira - Contacts, Employees, Board Members, Advisors & Alumni
Nuvaira is a new alternative COPD treatment option that specializes in developing devices for treating lung diseases. ... Experience the new Crunchbase, powered by AI . Experience the …See details»
Nuvaira Company Profile - Office Locations, Competitors ... - Craft
Nuvaira has 5 employees across 2 locations and $147.6 m in total funding,. See insights on Nuvaira including office locations, competitors, revenue, financials, executives, subsidiaries …See details»
Nuvaira - VentureRadar
Nuvaira is a privately held company headquartered in Minneapolis, Minn. The company has developed the Nuvaira Lung Denervation System to address chronic lung diseases by treating …See details»
Nuvaira - Raised $191M Funding from 13 investors - Tracxn
Mar 27, 2025 List of Nuvaira's institutional investors. USVP, located in Menlo Park (United States), made their first investment in Nuvaira on Feb 11, 2019 in its Series E round.; …See details»
NUVAIRA - Overview, News & Similar companies | ZoomInfo.com
Aug 10, 2021 Who is NUVAIRA. Nuvaira is a privately held company headquartered in Minneapolis, MN. The company's proprietary dNerva® Targeted Lung Denervation System …See details»
Holaira Announces Company Name Change to Nuvaira
Jul 11, 2017 The company is developing the Nuvaira Lung Denervation System to address chronic obstructive pulmonary disease by treating the overactive airway nerves during …See details»
200th Treatment Milestone for AIRFLOW-3 COPD Trial - Newswire
Jan 25, 2022 About Nuvaira Nuvaira is a privately held company headquartered in Minneapolis, MN. ... Organization Profile. Nuvaira. Contact Cision. 866-245-2317 from 8 AM - 10 PM ET …See details»
Lung device maker Nuvaira raises $15 million - USVP/
Dec 5, 2023 Lung device maker Nuvaira raises $15 million. December 5, 2023 | In Portfolio Company News | By usvpAdminer. Prev; Next; U.S. Venture Partners (USVP) is a leading …See details»
Nuvaira secures funds to develop lung denervation system
Feb 12, 2019 US-based medical device company Nuvaira has raised fresh funds in an equity financing round led by US Venture Partners to further develop its lung denervation system for …See details»
Nuvaira - USVP/
Nuvaira has developed the Nuvaira Lung Denervation System to treat patients with chronic obstructive pulmonary disease (COPD) refractory to drug […]See details»
Nuvaira: 10 Key Things You Must Know - zoonop.com
Overview. Nuvaira is a pioneering medical technology company renowned for its innovative solutions within the realm of pulmonary diseases. Established with the mission to advance …See details»
Minneapolis Lung Treatment Device Developer Nuvaira Raises $79M
Feb 11, 2019 Nuvaira, a Minneapolis-based developer of therapeutic medical devices for treating certain lung diseases, announced Monday it had closed a $79 million financing round. …See details»